BioCentury
ARTICLE | Financial News

Ziopharm raises $50M in private placement

November 16, 2018 3:56 PM UTC

Immunotherapy company Ziopharm Oncology Inc. (NASDAQ:ZIOP) raised $50 million through the sale of 18.9 million units at $2.64 in a private placement on Nov. 12. Each unit comprises one share and a five-year warrant to purchase one share at $3.01...

BCIQ Company Profiles

Alaunos Therapeutics Inc.